To solve a problem associated with novel nicotinic
agonists,9 we have developed an alternative approach to
4-substituted pyridines that avoids the use of a 4-halopyridine
altogether. Instead, directed and regioselective deprotonation
and transmetalation (Li f Zn),10 rather than direct halogen-
metal exchange, has been used to provide access to the key
organometallic (zinc) component, which is then suitable for
a Pd-mediated cross coupling. Importantly, this strategy has
a more general application and has been extended to provide
a flexible entry to functionalized variants of both 3,4- and
2,3-disubstituted pyridines.
of ZnCl2 (as a THF solution) was also done at -95 °C, and
warming of the solution to room temperature provided the
corresponding zinc species 2.12 This intermediate, which is
stable at room temperature, was then used directly as the
4-pyridyl organometallic component in cross coupling reac-
tions involving aryl and alkenyl halides/triflates. The overall
yields for deprotonation, lithium-zinc exchange, and cross
coupling were generally good, and the resulting 3-bromo-
4-substituted pyridines 313 were isolated following chroma-
tography (Figure 1).
The synthesis of 4-substituted and 3,4-disubstituted py-
ridines is outlined in Scheme 1 and is based on a one-pot/
Scheme 1. Directed Deprotonation/Transmetalation Route to
4-Substituted and 3,4-Disubstituted Pyridinesa
Figure 1. 3-Bromo-4-substituted pyridines. The superscripts a-d
denote the following: (a) using the corresponding iodide; (b) using
the aryl or alkenyl bromide; (c) using the alkenyl triflate, see ref
9a; (d) Voc ) vinyloxycarbonyl.
a Reagents and conditions: (a) LDA, THF, -95 °C; (b) ZnCl2,
-95 °C to rt; (c) ArX, Pd(Ph3P)4, reflux; (d) Rieke zinc, then H2O;
(e) Ar′B(OH)2, Pd(Ph3P)4, aqueous Na2CO3, EtOH, PhMe, or
H2CdCHR, Pd(OAc)2, (o-Tol)3P, NEt3, MeCN.
Interestingly, no “homocoupled” products with 2 acting
as both the aryl zinc and aryl bromide fragments were
observed; the reactivity associated with the aryl zinc
component of 2 appears to dominate. Reduction of 3 (Ar )
Ph, 4-ClC6H4) using Rieke zinc14 followed by an aqueous
quench then allowed access to the corresponding 4-mono-
substituted pyridines 4a and 4b in 81% and 64% overall
yields, respectively, from 3-bromopyridine, as shown in
Scheme 1.
three-step sequence: (i) the kinetic C(4) lithiation of
3-bromopyridine 1; (ii) a low-temperature Li-Zn exchange;
(iii) Pd(0)-mediated cross coupling of the resulting orga-
nozinc intermediate 2 using an aryl or alkenyl halide (or
triflate). In this way, 3-bromo-4-substituted pyridines 3 are
obtained, which then provide access to both 4-substituted
pyridines 4 (following reduction of 3) and, more significantly,
3,4-disubstituted pyridines 5 via a second Pd-mediated cross
coupling, based on use of 3 as the aryl halide component.
Deprotonation of 3-bromopyridine 1 was achieved using
LDA in THF at -95 °C as reported by Gribble.11 Addition
While reduction of 3 to give 4a/b is straightforward, the
reactivity associated with the 3-bromo substituent of 3 can
be harnessed in a synthetically more versatile manner,
(11) Gribble, G. W.; Saulnier, M. G. Tetrahedron Lett. 1980, 21, 4137-
4140.
(12) The monoalkyl zinc halide species is assumed. Lithium zincates
are known, see: Isobe, M.; Kondo, S.; Nagasawa, N.; Goto, T. Chem. Lett.
1977, 679-682.
(13) 3-Bromopyridine is known to undergo N-acylation and C(4) arylation
with ArMgX, to provide an alternative source of 3-bromo-4-arylpyridines.
Comins, D. L.; Mantlo, N. B. J. Heterocycl. Chem. 1983, 20, 1239-1243.
(14) Rieke, R. D.; Hanson, M. V. In Organozinc Reagents; Knochel, P.,
Jones, P., Eds.; Oxford University Press: Oxford, 1999; Chapter 2, pp 23-
36. Zhu, L.; Wehmeyer, R. M.; Rieke, R. D. J. Org. Chem. 1991, 56, 1445-
1453.
(15) For related Heck processes, see: Anson, M. S.; Mirza, A. R.; Tonks,
L.; Williams, J. M. J. Tetrahedron Lett. 1999, 40, 7147-7150. El-Ghayoury,
A.; Ziessel, R. Tetrahedron Lett. 1998, 39, 4473-4476.
(16) Also see: Marsais, F.; Bouley, F.; Que´guiner, G. J. Organomet.
Chem. 1979, 171, 273-282. For reviews relating to the deprotonation of
azines, see: Que´guiner, G.; Marsais, F.; Snieckus, V.; Epsztajn, J. In
AdVances in Heterocyclic Chemistry; Katritsky, A. R., Ed.; Academic
Press: San Diego, 1991; Vol. 52, pp 187-304. Que´guiner, G. J. Heterocycl.
Chem. 2000, 37, 615-621.
(9) (a) Wright, E.; Gallagher, T.; Sharples, C. G. V.; Wonnacott, S.
Bioorg. Med. Chem. Lett. 1997, 7, 2867-2870. (b) Sharples, C. G. V.;
Kaiser, S.; Soliakov, L.; Marks, M. J.; Collins, A. C.; Washburn, M.; Wright,
E.; Spencer, J. A.; Gallagher, T.; Whiteaker, P.; Wonnacott, S. J. Neurosci.
2000, 20, 2783-2791.
(10) For other examples of lithium-zinc transmetalations, see: Gros,
P.; Fort, Y. Synthesis 1999, 754-756. Kristensen, J.; Begtrup, M.; Vedsø,
P. Synthesis 1998, 1604-1608 (these authors use the term “ortho lithiation/
transmetalation”). Felding, J.; Uhlmann, P.; Kristensen, J.; Vedsø, P.;
Begtrup, M. Synthesis 1998, 1181-1184. Yagi, K.; Ogura, T.; Numata,
A.; Ishii, S.; Arai, K. Heterocycles 1997, 45, 1463-1466. Amat, M.; Hadida,
S.; Pshenichnyi, G.; Bosch, J. J. Org. Chem. 1997, 62, 3158-3175.
Anderson, B. A.; Harn, N. K. Synthesis 1996, 583-585. Sakamoto, T.;
Kondo, Y.; Takazawa, N.; Yamanaka, H. J. Chem. Soc., Perkin Trans. 1
1996, 1927-1934. Tre´court, F.; Gervais, B.; Mallet, M.; Que´guiner, G. J.
Org. Chem. 1996, 61, 1673-1676. Ennis, D. S.; Gilchrist, T. L. Tetrahedron
1990, 46, 2623-2632. Bell, A. S.; Roberts, D. A.; Ruddock, K. S.
Tetrahedron Lett. 1988, 29, 5013-5016.
836
Org. Lett., Vol. 3, No. 6, 2001